ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,578,000 | +69.7% | 34,065 | -10.7% | 0.18% | +54.4% |
| Q1 2019 | $930,000 | +65.2% | 38,144 | -3.5% | 0.11% | +39.0% |
| Q4 2018 | $563,000 | -20.6% | 39,519 | -15.3% | 0.08% | -16.3% |
| Q3 2018 | $709,000 | +90.6% | 46,669 | +110.5% | 0.10% | +71.9% |
| Q2 2018 | $372,000 | -100.0% | 22,170 | -52.8% | 0.06% | -53.3% |
| Q1 2018 | $766,632,000 | +32.9% | 46,975 | +4.2% | 0.12% | +31.2% |
| Q4 2017 | $576,960,000 | +882.3% | 45,075 | +844.0% | 0.09% | +830.0% |
| Q3 2017 | $58,733,000 | +47.0% | 4,775 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $39,967,000 | -6.4% | 4,775 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $42,689,000 | – | 4,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|